Compare ASTH & STDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTH | STDN |
|---|---|---|
| Founded | 1994 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Major Chemicals |
| Sector | Consumer Discretionary | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2015 | 2026 |
| Metric | ASTH | STDN |
|---|---|---|
| Price | $29.06 | $8.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $51.89 | $16.88 |
| AVG Volume (30 Days) | ★ 326.3K | 284.1K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $519,907,752.00 | N/A |
| Revenue This Year | $24.87 | $460.20 |
| Revenue Next Year | $9.94 | $249.04 |
| P/E Ratio | $30.21 | ★ N/A |
| Revenue Growth | ★ 45.90 | N/A |
| 52 Week Low | $18.08 | $7.05 |
| 52 Week High | $51.60 | $17.34 |
| Indicator | ASTH | STDN |
|---|---|---|
| Relative Strength Index (RSI) | 30.89 | 27.26 |
| Support Level | $23.00 | $7.05 |
| Resistance Level | $40.18 | $13.61 |
| Average True Range (ATR) | 2.30 | 1.02 |
| MACD | -0.65 | -0.37 |
| Stochastic Oscillator | 7.91 | 1.54 |
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Standard Nuclear Inc is an independent advanced nuclear fuel company. The company designs, engineers, and manufactures advanced nuclear fuels, with a primary focus on TRISO fuel for advanced reactors. Its operations include industrial-scale TRISO fuel manufacturing and the development of fuel for advanced reactors that utilize TRISO fuel. The company operates in a single operating and reportable segment, as it is engaged in a single business activity of TRISO production. It derives revenue from fuel development and services agreements. Geographically, the maximum revenue is generated from the United States.